Haemonetics Aktie

Haemonetics für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN: 881782 / ISIN: US4050241003

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
04.11.2020 12:14:34

Haemonetics Q2 Results Top Estimates - Quick Facts

(RTTNews) - Healthcare company Haemonetics Corp. (HAE) reported Tuesday that net income for the second quarter grew to $48.10 million or $0.94 per share from $37.49 million or $0.72 per share in the prior-year quarter. Excluding items, adjusted earnings were $0.62 per share, compared to last year's $0.87 per share.

Net revenue for the quarter decreased 17.1 percent to $209.49 million from last year's $252.57 million, primarily driven by the continued negative impact of COVID-19. Organic revenue was down 15.5 percent.

On average, analysts polled by Thomson Reuters expected the company to report earnings of $0.51 per share on revenue of $207.65 million for the quarter. Analysts' estimates typically exclude special items.

Looking ahead, the company said it did not issue fiscal 2021 guidance due to the continued uncertainty about the pace and timing of the COVID-19 pandemic and recovery.

Analysen zu Haemonetics Corp.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Haemonetics Corp. 59,00 0,00% Haemonetics Corp.